B Göke

888 total citations
35 papers, 583 citations indexed

About

B Göke is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, B Göke has authored 35 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Genetics. Recurrent topics in B Göke's work include Diabetes Treatment and Management (6 papers), Pancreatic function and diabetes (5 papers) and Pancreatitis Pathology and Treatment (4 papers). B Göke is often cited by papers focused on Diabetes Treatment and Management (6 papers), Pancreatic function and diabetes (5 papers) and Pancreatitis Pathology and Treatment (4 papers). B Göke collaborates with scholars based in Germany, Switzerland and United States. B Göke's co-authors include Rüdiger Göke, Joerg Schirra, Jürgen Drewe, Christoph Beglinger, Massimo D’Amato, Hans-Christoph Fehmann, Andreas Wilmen, A Wagner, Thomas Höfken and R. Arnold and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

B Göke

35 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Göke Germany 13 255 242 167 99 97 35 583
Cheryl A. Brighton United Kingdom 8 203 0.8× 234 1.0× 215 1.3× 39 0.4× 165 1.7× 10 565
Kevin Vivot France 14 183 0.7× 275 1.1× 279 1.7× 98 1.0× 113 1.2× 19 625
Neil Portwood Sweden 13 242 0.9× 179 0.7× 197 1.2× 301 3.0× 159 1.6× 21 735
Laurence E. Stout United States 14 245 1.0× 376 1.6× 276 1.7× 213 2.2× 52 0.5× 16 745
C. Beglinger Switzerland 15 156 0.6× 249 1.0× 105 0.6× 31 0.3× 57 0.6× 25 521
Emilie Balk-Møller Denmark 7 126 0.5× 130 0.5× 120 0.7× 27 0.3× 100 1.0× 7 343
Emilia Ottosson-Laakso Sweden 8 154 0.6× 251 1.0× 233 1.4× 182 1.8× 64 0.7× 11 492
L. J. Miller United States 12 122 0.5× 286 1.2× 180 1.1× 33 0.3× 46 0.5× 25 627
Augustinas Sakinis Sweden 12 156 0.6× 353 1.5× 202 1.2× 15 0.2× 106 1.1× 16 552
Caterina Formichi Italy 17 219 0.9× 184 0.8× 275 1.6× 115 1.2× 127 1.3× 27 731

Countries citing papers authored by B Göke

Since Specialization
Citations

This map shows the geographic impact of B Göke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Göke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Göke more than expected).

Fields of papers citing papers by B Göke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Göke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Göke. The network helps show where B Göke may publish in the future.

Co-authorship network of co-authors of B Göke

This figure shows the co-authorship network connecting the top 25 collaborators of B Göke. A scholar is included among the top collaborators of B Göke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Göke. B Göke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochsenkühn, Thomas, Florian Beigel, Kristel Van Steen, et al.. (2011). Rate of Malignancies and Infections in a Large Single Center Cohort of IBD Patients Treated With Thiopurines and Anti-TNF-Antibodies. Gastroenterology. 140(5). S–773. 1 indexed citations
2.
Göke, B. (2010). What are the Potential Benefits of Clinical β-Cell Imaging in Diabetes Mellitus?. Current Pharmaceutical Design. 16(14). 1547–1549. 9 indexed citations
3.
Wilmen, Andreas, et al.. (2009). The genomic organization of the human GLP-1 receptor gene. Experimental and Clinical Endocrinology & Diabetes. 106(4). 299–302. 2 indexed citations
4.
Kubisch, Christian, Florian Beigel, Stephan Ihrler, et al.. (2009). Oesophageal Ulceration after Selective Internal Radiation Therapy in a Patient with Carcinoma of Unknown Primary. Zeitschrift für Gastroenterologie. 48(5). 546–550. 1 indexed citations
5.
Göke, B, et al.. (2009). Akute Exazerbation einer chronischen Ösophagitis. DMW - Deutsche Medizinische Wochenschrift. 134(30). 1517–1519. 4 indexed citations
6.
Woerle, Hans J., Rainer Linke, Christoph Neumann, et al.. (2008). Impaired Hyperglycemia-Induced Delay in Gastric Emptying in Patients With Type 1 Diabetes Deficient for Islet Amyloid Polypeptide. Diabetes Care. 31(12). 2325–2331. 47 indexed citations
7.
Schäfer, Claus, et al.. (2007). B-cell lymphoma with bowel-to-bowel penetration diagnosed by double-balloon endoscopy. Endoscopy. 39(S 1). E204–E204. 2 indexed citations
8.
Storr, Martin, B Yüce, & B Göke. (2006). Perspektiven von Cannabinoiden in der Gastroenterologie. Zeitschrift für Gastroenterologie. 44(2). 185–191. 5 indexed citations
9.
Dambacher, Julia, Torsten Olszak, Martin Storr, et al.. (2006). IL-22 mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression. Zeitschrift für Gastroenterologie. 44(10). 1 indexed citations
10.
Reichen, Jürg, et al.. (2001). Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. European Journal of Gastroenterology & Hepatology. 13(8). 977–980. 17 indexed citations
11.
Höfken, Thomas, Nadine Keller, Frank Fleischer, B Göke, & A Wagner. (2000). Map Kinase Phosphatases (MKP's) Are Early Responsive Genes during Induction of Cerulein Hyperstimulation Pancreatitis. Biochemical and Biophysical Research Communications. 276(2). 680–685. 30 indexed citations
12.
Weber, Heike, A Wagner, Ludwig Jonas, et al.. (2000). Heat Shock Response is Associated with Protection Against Acute Interstitial Pancreatitis in Rats. Digestive Diseases and Sciences. 45(11). 2252–2264. 30 indexed citations
13.
Simon, Babette, Peter Barth, Nicole Prasnikar, et al.. (1998). Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.. PubMed. 58(8). 1583–7. 46 indexed citations
14.
Schirra, Jörg, Pius Hildebrand, C. Beglinger, et al.. (1998). Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus. Journal of Endocrinology. 156(1). 177–186. 54 indexed citations
15.
Göke, B, et al.. (1998). The evolving role of α-glucosidase inhibitors. Diabetes/Metabolism Reviews. 14(S1). S31–S38. 38 indexed citations
16.
Fehmann, H. C. & B Göke. (1997). The Insulinotropic Gut Hormone Glucagon-Like Peptide-1. 15 indexed citations
17.
Wilmen, Andreas, B Göke, & Rüdiger Göke. (1996). The isolated N‐terminal extracellular domain of the glucagon‐like peptide‐1 (GLP)‐1 receptor has intrinsic binding activity. FEBS Letters. 398(1). 43–47. 43 indexed citations
18.
Printz, H., et al.. (1995). "Human pancreas-specific protein" (procarboxypeptidase B): a valuable marker in pancreatitis?. PubMed. 10(3). 222–30. 7 indexed citations
19.
Schäfer, Claus, et al.. (1994). Effects of synthetic cyclic AMP analogs on amylase exocytosis from rat pancreatic acini. Canadian Journal of Physiology and Pharmacology. 72(10). 1138–1147. 8 indexed citations
20.
Fehmann, Hans-Christoph, Rüdiger Göke, & B Göke. (1992). Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin. Molecular and Cellular Endocrinology. 85(1-2). C39–C44. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026